Table 1.
Participant demographic, treatment, and health characteristics (N=283)
| Characteristic | Valid n | n | % |
|---|---|---|---|
|
| |||
| Female | 281 | 156 | 55.5 |
|
| |||
| Hispanic ethnicity | 282 | 25 | 8.9 |
|
| |||
| Race* | |||
| Native American | 283 | 12 | 4.2 |
| Asian | 283 | 4 | 1.4 |
| Native Hawaiian | 283 | 3 | 1.1 |
| African American | 283 | 13 | 4.6 |
| White | 283 | 254 | 89.8 |
|
| |||
| Education | 282 | ||
| High school or less | 76 | 27.0 | |
| Some college or technical school | 157 | 55.7 | |
| College or post college | 49 | 17.3 | |
|
| |||
| Currently employed | 281 | 158 | 56.2 |
|
| |||
| Past-year problems* | |||
| Prescription opioids | 283 | 173 | 61.1 |
| Heroin | 283 | 57 | 20.1 |
| Crack/cocaine | 283 | 27 | 9.5 |
| Marijuana | 283 | 22 | 7.8 |
| Methamphetamine | 283 | 17 | 6.0 |
| Alcohol | 283 | 45 | 15.9 |
| Tobacco | 283 | 102 | 36.0 |
|
| |||
| Lifetime opioid use* | |||
| Prescription opioids | 282 | 268 | 95.0 |
| Heroin | 282 | 131 | 46.5 |
| Both | 282 | 123 | 43.6 |
|
| |||
| Any intravenous drug use | 280 | 119 | 42.5 |
|
| |||
| Lifetime opioid treatment* | |||
| Methadone | 270 | 114 | 42.2 |
| Buprenorphine | 272 | 153 | 56.3 |
| Both | 269 | 59 | 21.9 |
| Neither | 269 | 64 | 23.8 |
|
| |||
| Fair or poor health | 283 | 85 | 30.1 |
|
| |||
| Pain* | |||
|
| |||
| Experience pain daily or constantly | 280 | 149 | 53.3 |
|
| |||
| Severe or very severe in past 4 weeks | 283 | 49 | 17.3 |
|
| |||
| Interfered with work quite a bit or extremely in past 4 weeks |
281 | 65 | 23.1 |
Items were not mutually exclusive and will not necessarily sum to 100%.